Clinical Trial Update: Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial, sponsored by Peptilogics, evaluating a DAIR (debridement, antibiotics, and implant retention) approach for periprosthetic joint infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Joint Infection

Drugs mentioned

• Peptilogics investigational therapy

Snippet

Sponsor: Peptilogics | Conditions: Joint Infection | Phase 1 | Status: COMPLETED